REGULATION OF THE CART GENE BY PROMOTER CIS-ELEMENTS
启动子 CIS-元件对 Cart 基因的调控
基本信息
- 批准号:8172381
- 负责人:
- 金额:$ 4.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-05-01 至 2011-04-30
- 项目状态:已结题
- 来源:
- 关键词:Addictive BehaviorAntibodiesBasic ScienceBehavioralBindingBiological AssayBrainCREB1 geneCell NucleusCellsChronicCocaineComputer Retrieval of Information on Scientific Projects DatabaseCultured CellsCyclic AMP Response ElementDataDrug abuseElementsFundingGene TransferGenesGoalsGrantInjection of therapeutic agentInstitutionIntakeLifeMediatingMessenger RNAMolecularMutationNucleus AccumbensOligonucleotidesPathway interactionsPeptidesPharmaceutical PreparationsPharmacotherapyRattusRegulationRelapseResearchResearch PersonnelResourcesRewardsSelf AdministrationSiteSourceSumTranscriptUnited States National Institutes of HealthWorkaddictionchromatin immunoprecipitationcocaine- and amphetamine-regulated transcript proteindrug cravingpreferencepromotertranscription factor
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
A major focus of drug abuse research is to elucidate the molecular mechanisms of addiction responsible for long-term behavioral abnormalities causing drug craving and repeated relapse. One goal of that basic research is identifying pharmacotherapy targets to develop medications. Chronic cocaine intake causes long-term genetic alterations in the brain reward pathway that contribute to addictive behaviors by up-regulating CREB transcription factor activity in nucleus accumbens (NAc).
Increases in CREB activity in NAc were correlated with decreases in the reinforcing effects of cocaine during conditioned place-preference and drug self-administration assays. The CART gene promoter was found to contain a cAMP response element (CRE) proposed to bind CREB, and CART mRNA was originally identified as a transcript in rat NAc up-regulated after cocaine administration. Intra-NAc injection of CART peptides blunted rewarding effects of cocaine in self administration assays. The overall hypothesis of this dissertation is that CART is a CREB-regulated gene.
The data collected during the project period demonstrated by chromatin immunoprecipitation assay that CREB and P-CREB in cultured cells were capable of binding to a region of the CART promoter containing the CRE site in nuclei of living cells. Furthermore, electrophoretic mobility shift and antibody super-shift assays revealed that CREB and P-CREB from rat NAc were able to bind to a short oligonucleotide identical in sequence to the CART promoter CRE site. In rat NAc, over-expression of CREB by virally mediated gene transfer increased CART mRNA and peptide levels. In sum, the body of data from this work strongly suggested that CREB and P-CREB regulated CART mRNA and peptide expression in rat NAc by acting directly at the CRE site in the CART proximal promoter. A mechanism by which CREB blunted the rewarding effects of cocaine may have been, in part, by increased expression of CART peptides in the NAc.
这个子项目是许多研究子项目中的一个
由NIH/NCRR资助的中心赠款提供的资源。子项目和
研究者(PI)可能从另一个NIH来源获得了主要资金,
因此可以在其他CRISP条目中表示。所列机构为
研究中心,而研究中心不一定是研究者所在的机构。
药物滥用研究的一个主要重点是阐明成瘾的分子机制,导致长期的行为异常,导致药物渴望和反复复发。 基础研究的一个目标是确定药物治疗目标以开发药物。 慢性可卡因摄入导致大脑奖赏途径的长期遗传改变,通过上调丘脑核(NAc)中的CREB转录因子活性而导致成瘾行为。
在条件性位置偏好和药物自我给药试验中,NAc中CREB活性的增加与可卡因强化作用的减少相关。 CART基因启动子被发现含有一个cAMP反应元件(CRE),建议结合CREB,CART mRNA最初被确定为可卡因给药后在大鼠NAc上调的转录本。 在自我施用测定中,CART肽的NAc内注射减弱了可卡因的奖励作用。 本论文的总体假设是,CART是一个CREB调控的基因。
在项目期间收集的数据通过染色质免疫沉淀试验证明,培养细胞中的CREB和P-CREB能够结合到活细胞核中含有CRE位点的CART启动子区域。 此外,电泳迁移率变化和抗体超位移测定显示,CREB和P-CREB从大鼠NAc能够结合到一个短的寡核苷酸序列相同的CART启动子CRE网站。 在大鼠NAc中,通过病毒介导的基因转移过度表达CREB增加了CART mRNA和肽水平。 总之,来自这项工作的大量数据强烈表明,CREB和P-CREB通过直接作用于CART近端启动子中的CRE位点来调节大鼠NAc中的CART mRNA和肽的表达。 CREB减弱可卡因奖赏效应的机制可能部分是通过增加NAc中CART肽的表达。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL J KUHAR其他文献
MICHAEL J KUHAR的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL J KUHAR', 18)}}的其他基金
TRAINING PROGRAM IN THE NEUROBIOLOGY OF DRUG ABUSE
药物滥用神经生物学培训计划
- 批准号:
8357409 - 财政年份:2011
- 资助金额:
$ 4.39万 - 项目类别:
REGULATION OF THE CART GENE BY PROMOTER CIS-ELEMENTS
启动子 CIS-元件对 Cart 基因的调控
- 批准号:
8357437 - 财政年份:2011
- 资助金额:
$ 4.39万 - 项目类别:
TRAINING PROGRAM IN THE NEUROBIOLOGY OF DRUG ABUSE
药物滥用神经生物学培训计划
- 批准号:
8172339 - 财政年份:2010
- 资助金额:
$ 4.39万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 4.39万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 4.39万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 4.39万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 4.39万 - 项目类别:
Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 4.39万 - 项目类别:
Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 4.39万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 4.39万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
- 批准号:
10639161 - 财政年份:2023
- 资助金额:
$ 4.39万 - 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
- 批准号:
10752441 - 财政年份:2023
- 资助金额:
$ 4.39万 - 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
- 批准号:
10867639 - 财政年份:2023
- 资助金额:
$ 4.39万 - 项目类别:














{{item.name}}会员




